By Josh White
Date: Friday 21 Feb 2025
(Sharecast News) - Proteome Sciences announced on Friday that it has secured a contract worth over $1m from a US biopharmaceutical company for the use of its mass spectrometry services in an ongoing clinical trial.
By Benjamin Chiou
Date: Monday 23 Dec 2024
(Sharecast News) - Shares in drug development services group Proteome Sciences rose on Monday after the company said 2024 results should reflect a good recovery and that its pipeline is looking strong for next year.
By Josh White
Date: Friday 13 Sep 2024
(Sharecast News) - Proteome Sciences announced a significant drop in first-half revenue and profit on Friday, alongside the departure of its chief executive.
Currency | UK Pounds |
Share Price | 3.34p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 4.80 |
52 Week Low | 2.50 |
Volume | 132 |
Shares Issued | 295.18m |
Market Cap | £9.86m |
Beta | 0.00 |
RiskGrade | 353 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
11:22 | 132 @ 3.78p |
You are here: research